CN113481279A - Method for detecting telomerase activity - Google Patents
Method for detecting telomerase activity Download PDFInfo
- Publication number
- CN113481279A CN113481279A CN202110745677.8A CN202110745677A CN113481279A CN 113481279 A CN113481279 A CN 113481279A CN 202110745677 A CN202110745677 A CN 202110745677A CN 113481279 A CN113481279 A CN 113481279A
- Authority
- CN
- China
- Prior art keywords
- telomerase
- detecting
- activity
- magnetic beads
- telomerase activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010017842 Telomerase Proteins 0.000 title claims abstract description 66
- 230000000694 effects Effects 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 33
- 238000006243 chemical reaction Methods 0.000 claims abstract description 28
- 239000003298 DNA probe Substances 0.000 claims abstract description 27
- 239000011324 bead Substances 0.000 claims abstract description 23
- 108091035539 telomere Proteins 0.000 claims abstract description 19
- 102000055501 telomere Human genes 0.000 claims abstract description 19
- 238000001514 detection method Methods 0.000 claims abstract description 17
- 239000000758 substrate Substances 0.000 claims abstract description 11
- 210000003411 telomere Anatomy 0.000 claims abstract description 11
- QRZUPJILJVGUFF-UHFFFAOYSA-N 2,8-dibenzylcyclooctan-1-one Chemical group C1CCCCC(CC=2C=CC=CC=2)C(=O)C1CC1=CC=CC=C1 QRZUPJILJVGUFF-UHFFFAOYSA-N 0.000 claims abstract description 9
- 150000001540 azides Chemical class 0.000 claims abstract description 9
- 108020003215 DNA Probes Proteins 0.000 claims abstract description 8
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 claims abstract description 6
- 108010090804 Streptavidin Proteins 0.000 claims abstract description 6
- 238000005859 coupling reaction Methods 0.000 claims abstract description 5
- 230000008878 coupling Effects 0.000 claims abstract description 4
- 238000010168 coupling process Methods 0.000 claims abstract description 4
- 239000000523 sample Substances 0.000 claims description 9
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 6
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 6
- 229960002685 biotin Drugs 0.000 claims description 5
- 239000011616 biotin Substances 0.000 claims description 5
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 claims description 4
- 238000007885 magnetic separation Methods 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 8
- 239000000047 product Substances 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 8
- 238000009396 hybridization Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 3
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 3
- 229960005156 digoxin Drugs 0.000 description 3
- 238000002795 fluorescence method Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 238000007447 staining method Methods 0.000 description 3
- 241000701447 unidentified baculovirus Species 0.000 description 3
- ZUHQCDZJPTXVCU-UHFFFAOYSA-N C1#CCCC2=CC=CC=C2C2=CC=CC=C21 Chemical compound C1#CCCC2=CC=CC=C2C2=CC=CC=C21 ZUHQCDZJPTXVCU-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 2
- 102100034349 Integrase Human genes 0.000 description 2
- 238000000376 autoradiography Methods 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 2
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000003904 radioactive pollution Methods 0.000 description 2
- 210000001082 somatic cell Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 1
- 101710121417 Envelope glycoprotein Proteins 0.000 description 1
- 101001001300 Human cytomegalovirus (strain Towne) 65 kDa phosphoprotein Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 239000012327 Ruthenium complex Substances 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- 208000035896 Twin-reversed arterial perfusion sequence Diseases 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007413 biotinylation Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000010249 in-situ analysis Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/91245—Nucleotidyltransferases (2.7.7)
- G01N2333/9125—Nucleotidyltransferases (2.7.7) with a definite EC number (2.7.7.-)
- G01N2333/9128—RNA-directed DNA polymerases, e.g. RT (2.7.7.49)
Abstract
The invention discloses a method for detecting telomerase activity, which comprises the following steps: firstly, performing extension reaction on streptavidin modified magnetic beads and biotinylated telomerase substrate primers to prolong and generate a telomere repeat sequence of TTAGGG; coupling the Azide modified DNA probe with a DBCO group on dUTP through a click chemistry reaction to generate a plurality of DNA probes with side chains; triggering another two hairpin DNA probes H1 and H2 to assemble to generate a long-chain assembly product; and step four, detecting the fluorescence on the surface of the magnetic beads through a fluorescence detector to realize the detection of the activity of the telomerase. The invention has accurate and reliable detection result and high sensitivity.
Description
Technical Field
The invention belongs to the technical field of microorganisms, and particularly relates to a method for detecting telomerase activity.
Background
Telomerase is a special reverse transcriptase consisting of RNA and protein, involved in the synthesis of telomeres (a specific nucleotide sequence and structure) at the DNA terminus of eukaryotic cells. The telomere length of normal somatic cells is gradually shortened along with the division of the cells, the activity of telomerase is enhanced, the telomere length can be kept not to be shortened, and the cells are permanently proliferated to become cancerous. Therefore, telomerase detection and inhibitors thereof can be used for tumor diagnosis and treatment.
The detection of telomerase is suitable for diagnosis and differential diagnosis of various tumor diseases. For example, small cell lung cancer has increased telomerase activity in its early stage, and non-small cell lung cancer has more activity changes than in its middle and late stages.
Telomerase has been of interest in recent years due to its association with studies of longevity, cancer, and the like. The telomerase can copy and synthesize a telomere sequence by taking a template region of self RNA as a template. The telomerase activity is realized in cells with active proliferation such as embryonic cells, the telomerase is inactivated in normal mature somatic cells, and meanwhile, most of tumor cells are found to be telomerase positive, while the positive rate of the telomerase in tissues beside cancers and normal tissues is low, so that the telomerase is presumed to be a wide tumor marker.
At present, methods for detecting telomerase mainly include an isotope method, a staining method, a fluorescence method and an ELISA method.
1. Isotope method. Isotopic methods are most used. There are many reports of incorporation using [ α -32P ] dGTP or dCTP, but some scholars label the 5' end of the TS primer with [ γ -32P ] dATP and T4 kinase, and find that low levels of telomerase are more easily detected and more easily quantified. The gel was run on a PAGE gel and then examined for 3h by autoradiography on an X-ray film or by scanning with a Phosphoimager. The isotope method has the advantages of high sensitivity, detection of 100 immortalized cells for 27 cycles, radioactive pollution, and long time for autoradiography which takes more than 8 hours to two days.
2. And (3) dyeing. After electrophoresis, the gel is stained with SYBR green or EB, and then observed under an ultraviolet lamp or measured by a CCD image system. EB has the best effect under a 302nm ultraviolet transilluminator and an orange-red ultraviolet filter, and can obtain sensitivity similar to SYBR green. The staining method is simple and rapid, the sensitivity is 100 immortalized cells for 30 cycles, and the signal intensity of the staining band can not accurately reflect the number of molecules (the large fragment stains more strongly), so the staining method can only judge the relative telomerase activity, but can not determine the exact number of the telomerase extension product.
3. Fluorescence method. Add 10pmol fluorescein labeled (such as FAM, FITC) TS and/or CX primer amplification, through 8% denaturing PAGE gel electrophoresis, DNA sequencer automatically read the value, fragment management system software automatically calculate the scanning curve peak height and peak area, from the loading to the results only need 90 min. The fluorescence system is extremely sensitive, in order to avoid the unreliable result possibly given by the excessive amplification product, the low protein content of 0.5-1.0 mu g is used, the 27 cycles of amplification are carried out, and the fragment management system can automatically detect very weak fluorescence, so that the activity of the low-level telomerase can not be accurately measured [ 8-11 ]. Another application of fluorescence is in situ-TRAP assays, where telomerase activity can be detected at the cellular level, thus allowing one to determine which cells, how many cells, have telomerase activity, and the source of cells for which activity cannot be known by lytic extraction. In situ analysis was performed on a siliconized slide and the results were observed under a fluorescent microscope. At present, the method is only used for fresh specimens, the experiment for freezing and storing pathological specimens is not successful, and the improvement method is needed to prevent the dispersion of intracellular telomerase in freeze thawing, increase the permeability of the specimens and the like.
4. Marking biotin at the 5' end of the TS primer by ELISA method, after PCR amplification, denaturing the product, adding a digoxin-labeled probe which can be specifically combined with the repeated segment of the amplification product, combining the biotin on the hybridization product with the avidin fixed on the micropore plate, combining the digoxin on the probe with peroxidase-labeled anti-digoxin antibody, then adding a substrate, and measuring by using an enzyme-labeling instrument after color development. The ELISA method was used in a Boehringer's kit, and a ladder band differing by 6bp was not observed because of the absence of electrophoresis.
The isotope method has high sensitivity and is most applied, but radioactive pollution exists, the time is long, the dyeing method is simple and convenient to operate, the time is short, but only relative telomerase activity can be detected, and the fluorescence method is only used for fresh samples, so that a novel telomerase detection method is required to be provided, the accuracy of a detection result can be ensured, and the method is safe and reliable.
Disclosure of Invention
Based on this, it is therefore a primary object of the present invention to provide a method for detecting telomerase activity, which is capable of safely and reliably detecting telomerase activity, and which has high detection sensitivity and accuracy.
Another object of the present invention is to provide a method for detecting telomerase activity, which produces an assembly product with a plurality of fluorophores, so that fluorescence on the surface of magnetic beads can be detected by a fluorescence detector, thereby realizing accurate detection of telomerase activity.
In order to achieve the purpose, the technical scheme of the invention is as follows:
a method for detecting telomerase activity, the method comprising:
firstly, performing extension reaction on streptavidin modified magnetic beads and biotinylated telomerase substrate primers to prolong and generate a telomere repeat sequence of TTAGGG;
coupling the Azide modified DNA probe with a DBCO group on dUTP through a click chemistry reaction to generate a plurality of DNA probes with side chains;
triggering another two hairpin DNA probes H1 and H2 to assemble to generate a long-chain assembly product;
and step four, detecting the fluorescence on the surface of the magnetic beads through a fluorescence detector, and further realizing the detection of the activity of telomerase.
Specifically, in the first step, streptavidin modified magnetic beads and biotinylated telomerase substrate primers (TS primers) are connected through a streptavidin-biotin reaction, and the TS primers perform an extension reaction in the presence of telomerase to prolong the telomere repeat sequences of TTAGGG.
When 5-DBCO-PEG4-dUTP, dATP and dGTP are added in the extension reaction process, the repeated sequence of TTUGGG is extended. The U base in the extension product can generate click chemistry reaction because the DBCO group (the DBCO group is dibenzocyclooctyne: a reaction group of click chemistry) is modified, so that the coupling reaction with a DNA probe can be conveniently generated.
In the second step, an Azide (Azide) modified DNA probe is designed to be coupled with the DBCO group on dUTP through a click chemistry reaction, so that the telomerase extension product can click on the DNA probes with a plurality of side chains. This DNA strand can be designed as a trigger strand for a hybridization chain reaction.
In step three, the assembly of two additional hairpin DNA probes (H1 and H2) is triggered, resulting in a long-chain assembly product. When FAM (a fluorophore) is labeled on the other two hairpin DNA probes, the assembly product can have many fluorophores.
In the fourth step, redundant probes H1 and H2 can be washed away through a magnetic separation experiment, and then fluorescence on the surface of the magnetic beads is detected through a fluorescence detector, so that the detection of the activity of telomerase is realized.
Further, in the method, the probe sequence is
The invention has the beneficial effects that:
the method comprises the steps of firstly enabling streptavidin modified magnetic beads and biotinylated telomerase substrate primers to perform extension reaction, extending and generating telomere repetitive sequences of TTAGGG, then performing coupling to generate DNA probes with a plurality of side chains, so that telomerase extension products can click on the DNA probes with the plurality of side chains, and then generating long-chain assembly products on the basis of the DNA probes, wherein the assembly products have a plurality of fluorescent groups, and the fluorescence on the surfaces of the magnetic beads is detected by a fluorescence detector, so that the detection of the activity of telomerase is realized.
The detection method has accurate and reliable detection result and high sensitivity.
Drawings
FIG. 1 is a flow chart of a method implemented by the present invention.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is described in further detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
As shown in FIG. 1, the present invention is a schematic diagram of a baculovirus fluorescent nanoprobe realized by labeling baculovirus envelope glycoprotein GP64 by self-biotinylation and then labeling its genome with ruthenium complex using replication and self-assembly process of baculovirus [ Ru (phen ]2dppz]2+And (3) preparing.
And connecting the streptavidin modified magnetic beads with biotinylated telomerase substrate primers (TS primers) through a streptavidin-biotin reaction, wherein the TS primers generate an extension reaction under the condition that telomerase exists, and the telomere repetitive sequence of TTAGGG is generated by extension. When 5-DBCO-PEG4-dUTP, dATP and dGTP are added in the extension reaction process, the repeated sequence of TTUGGG is extended. The U base in the extension product can undergo click chemistry reaction due to the modification of DBCO group (dibenzocyclooctyne: a reaction group of click chemistry). An Azide (Azide) modified DNA probe is designed to be coupled with DBCO groups on dUTP through a click chemistry reaction, so that a telomerase extension product can click on DNA probes with a plurality of side chains. This DNA strand can be designed as a trigger strand for hybridization chain reaction, which can trigger the assembly of two other hairpin DNA probes (H1 and H2) to generate a long-chain assembly product. When FAM (a fluorophore) is labeled on the other two hairpin DNA probes, the assembly product can have many fluorophores. Redundant H1 and H2 probes can be washed away through a magnetic separation experiment, and then fluorescence on the surfaces of the magnetic beads is detected through a fluorescence detector, so that the activity of telomerase is detected.
Wherein the probe sequence is
The experimental procedure was as follows:
first, 10. mu.L of magnetic beads were added, the supernatant was removed by attracting the magnetic beads with a magnet, 10. mu.L of 1 XPBS was added, 5. mu.L of TS primer (10. mu.M) was added, and the mixture was allowed to stand at room temperature for 30 min. The TS primers not bound to the magnetic beads were removed by magnet, 25. mu.L of telomerase substrate primer extension system (1 XPCR buffer 22.5. mu. L, dATP (2.5mM, 0.5. mu.L), dAGP (2.5mM, 0.5. mu.L), 5-DBCO-PEG4-dAUP (2.5mM, 0.5. mu.L), 1. mu.L of telomerase, extension at 37 ℃ for 1H, supernatant removed by magnet, 1 XSSC 10. mu.L, T1 (10. mu.M, 5. mu.L), reaction at 30 ℃ for 1H, supernatant removed by magnet, H1 (10. mu.M) and H2 (10. mu.M) each 10. mu.L, hybridization reaction at 30 ℃ for 2H, magnetic beads washed with 1 XPCR PBS multiple times, and the results were observed under a fluorescent microscope.
② the extension of telomerase is firstly carried out. Telomerase diluted with lysis solution was added to a telomerase substrate primer extension system (TS primer (10. mu.M) 5. mu.L, 1 XPCR buffer 22.5. mu. L, dATP (2.5mM, 0.5. mu.L), dAGP (2.5mM, 0.5. mu.L), 5-DBCO-PEG4-dAUP (2.5mM, 0.5. mu.L), extended at 37 ℃ for 1H, 10. mu.L of magnetic beads were added, left to stand at room temperature for 30min, the supernatant was aspirated with a magnet, 1 XSSC 10. mu.L was added, T1 (10. mu.M, 5. mu.L) was added, the supernatant was aspirated with a magnet, 10. mu.L each of H1 (10. mu.M) and H2 (10. mu.M) was added, the hybridization reaction was performed at 30 ℃ for 2H, the magnetic beads were washed with 1 XPBS several times, and the results were observed with a fluorescence detector (fluorescence spectrometer, fluorescence microscope, etc.).
In a word, the streptavidin-modified magnetic beads and biotinylated telomerase substrate primers are subjected to extension reaction to generate a telomere repetitive sequence of TTAGGG by extension, and then are coupled to generate DNA probes with a plurality of side chains, so that the telomerase extension products can click on the DNA probes with the plurality of side chains, and then long-chain assembly products are generated on the basis of the DNA probes, wherein the assembly products have a plurality of fluorescent groups, and the fluorescence on the surfaces of the magnetic beads is detected by a fluorescence detector, so that the activity of telomerase is detected.
The detection method has accurate and reliable detection result and high sensitivity.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents and improvements made within the spirit and principle of the present invention are intended to be included within the scope of the present invention.
Claims (7)
1. A method for detecting telomerase activity, the method comprising:
firstly, performing extension reaction on streptavidin modified magnetic beads and biotinylated telomerase substrate primers to prolong and generate a telomere repeat sequence of TTAGGG;
coupling the Azide modified DNA probe with a DBCO group on dUTP through a click chemistry reaction to generate a plurality of DNA probes with side chains;
triggering another two hairpin DNA probes H1 and H2 to assemble to generate a long-chain assembly product;
and step four, detecting the fluorescence on the surface of the magnetic beads through a fluorescence detector, and further realizing the detection of the activity of telomerase.
2. The method for detecting telomerase activity as claimed in claim 1, wherein in step one, streptavidin-modified magnetic beads are linked to biotinylated telomerase substrate primers via a streptavidin-biotin reaction, and the TS primer undergoes an extension reaction in the presence of telomerase to extend the telomeric repeats that produce TTAGGG.
3. The method for detecting telomerase activity as claimed in claim 2, wherein the 5-DBCO-PEG4-dUTP, dATP, dGTP, is designed to extend beyond the TTUGGG repeat sequence during the extension reaction.
4. The method for detecting telomerase activity as claimed in claim 1, wherein in step two, an Azide (Azide) modified DNA probe is designed to couple with the DBCO group on dUTP by click chemistry, and the telomerase extension product will click on the DNA probe with many side chains.
5. The method for detecting telomerase activity as claimed in claim 1, wherein in step three, when FAM is labeled on the other two hairpin DNA probes, the assembly product has a plurality of fluorophores.
6. The method for detecting telomerase activity as claimed in claim 1, wherein in step four, excess H1 and H2 probes are washed away by magnetic separation assay, and fluorescence on the surface of the magnetic beads is detected by a fluorescence detector.
7. The method for detecting telomerase activity of claim 1, wherein the probe sequence is:
Bio-TS primer 5’-Biotin-TTTTTTAATCCGTCGAGCAGAGTT-3’;
T1(Azide-probe)5’-N3-AGTCTAGGATTCGGCGTGGGTTAA-3’;
H1 5’-FAM-TTAACCCACGCCGAATCCTAGACTCAAAGTAGTCTAGGATTCGGCGTG-3’
H2 5’-FAM-AGTCTAGGATTCGGCGTGGGTTAACACGCCGAATCCTAGACTACTTTG-3’。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110745677.8A CN113481279A (en) | 2021-07-01 | 2021-07-01 | Method for detecting telomerase activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110745677.8A CN113481279A (en) | 2021-07-01 | 2021-07-01 | Method for detecting telomerase activity |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113481279A true CN113481279A (en) | 2021-10-08 |
Family
ID=77939277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110745677.8A Pending CN113481279A (en) | 2021-07-01 | 2021-07-01 | Method for detecting telomerase activity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113481279A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106811524A (en) * | 2017-01-19 | 2017-06-09 | 陕西师范大学 | A kind of telomerase activation colorimetric detection method |
CN109517880A (en) * | 2018-11-15 | 2019-03-26 | 中山大学 | The method of gold nanoparticle detection urine Telomerase Activity based on chain replacement reaction and DNA modification |
CN112410400A (en) * | 2019-08-22 | 2021-02-26 | 深圳市第二人民医院 | Telomerase activity detection kit and telomerase activity detection method |
-
2021
- 2021-07-01 CN CN202110745677.8A patent/CN113481279A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106811524A (en) * | 2017-01-19 | 2017-06-09 | 陕西师范大学 | A kind of telomerase activation colorimetric detection method |
CN109517880A (en) * | 2018-11-15 | 2019-03-26 | 中山大学 | The method of gold nanoparticle detection urine Telomerase Activity based on chain replacement reaction and DNA modification |
CN112410400A (en) * | 2019-08-22 | 2021-02-26 | 深圳市第二人民医院 | Telomerase activity detection kit and telomerase activity detection method |
Non-Patent Citations (1)
Title |
---|
俸家富等, 四川科学技术出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ito et al. | Fluorescent differential display: Arbitrarily primed RT‐PCR fingerprinting on an automated DNA sequencer | |
WO2020243978A1 (en) | Primer for specific detection of human source genomic dna and application thereof | |
CN106591438A (en) | Nucleic acid combination for detecting Her2 gene, kit and application | |
CN108085395A (en) | Primer sets, kit and the method for cervical carcinoma polygenes DNA methylation assay based on high-flux sequence | |
CN109706232A (en) | For detecting primer, probe and the kit and its detection method of the fusion mutation of mankind's ALK gene | |
CN109456968A (en) | Tumor marker STAMP-EP5 based on methylation modification | |
CN113388668A (en) | Method for detecting exosome miRNA (micro ribonucleic acid) by local catalytic hairpin self-assembly technology based on DNA (deoxyribonucleic acid) nanowires | |
CN109251960A (en) | Detection Dam methyl transferase activity method based on base excision repair induction | |
CN114381550B (en) | Multi-target nucleic acid detection kit and detection method for HPV (human papilloma Virus) typing | |
CN106319062A (en) | Minimally invasive kit for assistant diagnosis or efficacy prediction of efficacy prediction | |
CN108949929A (en) | For detecting the product and its methods and applications of MTHFR and MTRR gene pleiomorphism simultaneously | |
WO2011012764A2 (en) | Method for identifying senescent mesenchymal stem cells | |
Liehr | Cytogenetics and molecular cytogenetics | |
CN113481279A (en) | Method for detecting telomerase activity | |
CN106319069A (en) | Kit for accurately determining pathogen cells and application of kit | |
US20230026916A1 (en) | Viral Oncogene Influences and Gene Expression Patterns as Indicators of Early Tumorigenesis | |
CN105950787A (en) | TORCH detection parallel probes, gene chip, kit and detection method | |
CN110172512A (en) | A kind of application of carcinoma of endometrium biomarker in cancer diagnosis and the prediction of prognosis situation | |
CN109295223A (en) | The optimization method and testing product of EGFR gene E19del mutation digital pcr detection architecture | |
WO2017114005A1 (en) | Terc gene and/or myc gene detection probe, preparation method therefor, and reagent kit | |
CN115094063A (en) | Multivalent activatable aptamer probe for early intelligent diagnosis of lung cancer and preparation and application thereof | |
CN107099606A (en) | A kind of probe groups, kit and the method for the gene magnifications of quick detection HER 2 | |
EP2843047B1 (en) | Nucleic acid detection method | |
CN113186321A (en) | Absolute fluorescence quantitative PCR (polymerase chain reaction) detection method for blastocyst protozoa | |
CN110042159A (en) | A kind of polymerase spiral amplimer group and detection kit based on Human colorectal carcinoma related gene SEPT9 DNA methylation assay |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211008 |
|
RJ01 | Rejection of invention patent application after publication |